Predicting survival of advanced stage cancer patients by simple prognostic score method
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Metastatic Breast Cancer, Recurrent ca Ovary and also Metastatic Gall Bladder, Pancreas & Gastric cancer
- Registration Number
- CTRI/2017/12/010807
- Lead Sponsor
- Tata Memorial Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 360
Inclusion Criteria
Patients with advanced metastatic solid tumours:
1)Metastatic breast cancer who have received at least 2 lines of chemotherapy in metastatic setting and progressed thereafter.
2)Recurrent ovarian cancer who have received at least 2 lines of chemotherapy for recurrent disease and progressed thereafter
3)Gastric/Gall bladder/Pancreatic cancer patients who have received at least 1 line of chemotherapy and progressed thereafter
Exclusion Criteria
Not willing to consent for participation or not willing to be followed-up
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survivalTimepoint: Every 3 months from enrollements in study upto 2 years
- Secondary Outcome Measures
Name Time Method Overall survivalTimepoint: Every 3 months from enrollements in study upto 2 years